10.3  -0.02 (-0.19%)		07-28 15:51
Open: 10.3 High: 10.32 Volume: 2,248		Pre. Close: 10.32 Low: 10.29 Market Cap: 264(M)

Short term
Mid term
Targets	6-month :	12.06	1-year :	14.09
Resists	First :	10.32	Second :	12.06
Pivot price	10.3
Supports	First :	10.28	Second :	10.25
MAs	MA(5) :	10.31	MA(20) :	10.29
	MA(100) :	10.21	MA(250) :	10.01
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	83.3	D(3) :	83.8
RSI	RSI(14): 64.4
52-week	High :	11.22	Low :	9.68

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ DALS ] has closed below upper band by 21.4%. Bollinger Bands are 9.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	10.33 - 10.38	10.38 - 10.42
Low:	10.2 - 10.26	10.26 - 10.31
Close:	10.23 - 10.32	10.32 - 10.4

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Tue, 01 Aug 2023
Deerfield Management Company, L.P. (Series C) Boosts Holding in DA32 Life Science Tech ... - Yahoo Finance

Fri, 21 Jul 2023
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares - Business Wire

Tue, 08 Mar 2022
Ciao! Allego revs up in Italy. PAQC has a DA. TuSimple stock crashes. - TheStreet

Thu, 06 Jan 2022
Trump-Related SPACs DWAC and CFVI Jump on Truth Social Launch News - TheStreet

Fri, 22 Oct 2021
Trump SPAC DWAC Rises over 100% Again to Cap Wild Week - TheStreet

Wed, 28 Jul 2021
DA32 Life Science SPAC Prices $200M IPO - BioSpace

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	21 (M)
Shares Float	17 (M)
Held by Insiders	7 (%)
Held by Institutions	104.3 (%)
Shares Short	2 (K)
Shares Short P.Month	1 (K)

EPS	0.05
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.21
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	172
PEG Ratio	0
Price to Book value	-51.6
Price to Sales	0
Price to Cash Flow	-173.26

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.